Patent · US Active

Compositions and methods of cellular immunotherapy

US11419895B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

CRAGE MEDICAL CO., LIMITED · CN

Inventors

Zonghai LI · Shanghai, CN
Peng Wang · Carlsbad, US
Hua Jiang · Shanghai, CN

Key dates

Filing date	May 30, 2018
Grant date	Aug 23, 2022
Priority date	—
Expiry date	Aug 8, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/33
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods of treating a subject exhibiting a cell that expresses Wilms tumor protein 1 (WT1). The methods typically utilize anti-WT1 antigen binding units or chimeric antigen receptor immunoresponsive cells to a subject in need thereof to effect killing of tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.